Shuttle Pharmaceuticals
SHPH
3 hedge funds and large institutions have $49.2K invested in Shuttle Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 5 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
63% less funds holding
Funds holding: 8 → 3 (-5)
81% less capital invested
Capital invested by funds: $265K → $49.2K (-$215K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
-$33K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$32.3K |
| 3 |
VF
Virtu Financial
New York
|
-$31K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$28.7K |
| 5 |
Goldman Sachs
New York
|
-$24.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Qube Research & Technologies (QRT)
London,
United Kingdom
| $32.7K | -$28.7K | -8 | -40% |
|
2
Millennium Management
New York
| $14K | -$17.9K | -5 | -50% |
|
|
FDCDDQ
3
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2.53K | – | – | – |
|
|
4
SG Americas Securities
New York
| – | -$33K | -8 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | -$32.3K | -8 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | -$31K | -8 | Closed |
|
|
7
Goldman Sachs
New York
| – | -$24.4K | -6 | Closed |
|
8
Two Sigma Investments
New York
| – | -$23.1K | -6 | Closed |
|
9
UBS Group
Zurich,
Switzerland
| – | -$951 | – | – |
|
SHPH Hedge Fund Activity: Q1 2023 in Review
3 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Shuttle Pharmaceuticals (SHPH) for Q1 2023, worth a combined $49.2K — down 81% from $265K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SHPH and 0 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was SG Americas Securities, exiting entirely with an estimated $33K sold.
- 3 institutional investors held Shuttle Pharmaceuticals (SHPH) as of Q1 2023, down from 8 in Q4 2022.
- Funds reported $49.2K of Shuttle Pharmaceuticals stock for Q1 2023, down 81% quarter-over-quarter.
- 0 funds opened new Shuttle Pharmaceuticals positions in Q1 2023 and 5 closed out, a net change of -5 holders.
- The largest Shuttle Pharmaceuticals seller in Q1 2023 was SG Americas Securities, an estimated $33K sold.
Based on aggregated 13F filings for Q1 2023.